Legal Representation
Attorney
Kongsik Kim
USPTO Deadlines
Next Deadline
73 days remaining
NOA E-Mailed - SOU Required
Due Date
March 16, 2026
Extension Available
Until September 16, 2026
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 14, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Sep 16, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 22, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jul 22, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 16, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 18, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 17, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 17, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 17, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 27, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 27, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 26, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 2, 2024 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
| Oct 2, 2024 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Sep 19, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of pharmaceuticals for others; Research and development of pharmaceuticals for others related to cancer, infectious diseases, and viral related diseases and disorders; Research and development of substances containing multispecific antibodies for degrading receptors and extracellular proteins; Medical research; Medical research laboratories; Medical and scientific research in the field of cancer, infectious diseases, and viral related diseases and disorders; Clinical research in the field of cancer, infectious diseases, and viral related diseases and disorders; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Compiling data for research purposes in the field of medical science and medical consultancy
Additional Information
Pseudo Mark
Ab Reptor
Classification
International Classes
042